Bend Bioscience News and Activities

Bend Bioscience is owned by Alkermes.

Alkermes is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Alkermes is a company listed under the stock ticker ALKS (US).

Alkermes has a direct presence in 2 countries.

They are in:

• Biotechnology50%
• Pharmaceuticals50%

Acquisition, funding and merger involving Alkermes.

• Alkermes has announced the acquisition of Avadel Pharmaceuticals  (posted on November 19 2025).

View the org chart displaying its 12 main executives

Most searched biographies at Bend Bioscience

• Owen Murray, Chief Executive Officer
• Wayne Weisman, Chairman of the Board
• Rick Schindewolf, Chief Financial Officer

Popular executive movements at Alkermes

• Tom Skoff, who was Vice President Information Technology, is promoted to Senior Vice President, Chief Information Officer  (posted on April 15 2026).
• Jenna Herby has joined the company as Senior Clinical Trial Manager  (posted on April 15 2026).
• Thomas Harvey, Chief Information Officer and Senior Vice President, Information Technology, has left the company  (posted on April 15 2026).

Click here to view some more movements at Alkermes

Create your alert
to follow the executive moves at Bend Bioscience.

Alkermes has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Bend Bioscience

• Bend Bioscience Advances Workforce Growth and Community Investment – Bend Bioscience
• News » Bend Bioscience
• CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
• Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
• Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
• Press Releases
• Societal CDMO Reports Inducement Grants for New Staff
• Societal CDMO Reports Third Quarter 2023 Financial Results
• Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023
• Societal CDMO Reports Inducement Grants for New Staff
• View more press releases Close

Social media about Bend Bioscience

• Bend Bioscience on Wikipedia, Google News & Yahoo Finance
• Bend Bioscience on LinkedIn, X (Twitter) & YouTube